IHC results obtained in PT9 and PT10 PDX models showed that tumor growth and the expression of HIF1A, VEGFA1 and Ki-67 were efficiently suppressed by treatment with PX-478, alone or in combination with neratinib (Figure 4 and Figure 5). This evidence concerns the gene HIF1A and neoplasm.